This week, our guests are chief scientific officer of Valo Health, Karin Conde-Knape, and Karsten Eastman, CEO of Sethera Therapeutics.

Times:

03:06 Sethera Therapeutics

20:08 Valo Health

Valo Health

Our guest from Valo Health is chief scientific officer Karin Conde-Knape. As head of global drug discovery at Novo Nordisk, she helped expand the company’s research pipeline to more than 100 programmes across new therapeutic areas, including cardiovascular and liver diseases. Earlier this year, she joined Valo Health, bringing AI, real-world patient data and predictive chemistry to rethink drug discovery from the ground up.

Valo Health said it is redefining drug discovery and development through its AI-enabled human c ...